| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.081 | 0.1 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.063 | 0.1 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.063 | 0.1 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.084 | 0.1 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |